drugset / Trial / NCT03102359

Brain Protection Effect of Selective Head Cooling and Dexmedetomidine in Patients Undergoing Liver Transplantation

NCT03102359

Phase 2 Unknown 100 enrolled Huazhong University of Science and Technology
RandomizedParallel-groupDouble-blindPrevention

Summary

The investigators investigated in the present study whether selective head cooling and dexmedetomidine has an effect on cerebral oxygenation during liver transplantation and has cerebral protective effect in patients undergoing liver transplantation.

Timeline

Start
2017-04-05
Primary completion
2019-12-31
Completion
2019-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous

Indications

No indication recorded.